Other downstream PKC-α targets can be examined as well to further understand the roles of PKC-α in striated muscle laminopathies, and to identify other proteins that could potentially be therapeutic targets to treat striated muscle laminopathies. This evidence concerns the gene PRKCA and laminopathy.